PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis
2022 · Nature Cell Biology · 504 citations
https://doi.org/10.1038/s41556-021-00818-3
H
Hai‐Liang Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
1.9K
Citations
16
h-index
22
i10-index
Hai‐Liang Zhang is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Renal cell carcinoma treatment & Cancer Immunotherapy and Biomarkers & Ferroptosis and cancer prognosis. The author has an h-index of 16, co-authored 68 publications.
Papers by this author
worksFis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis
2021 · Signal Transduction and Targeted Therapy · 134 citations
https://doi.org/10.1038/s41392-021-00790-2
Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis
2023 · Redox Biology · 93 citations
https://doi.org/10.1016/j.redox.2023.102677
Cancer biomarkers discovered using pan-cancer plasma proteomic profiling
2025 · Nature Biomedical Engineering · 4 citations
https://doi.org/10.1038/s41551-025-01448-y
A novel synthesised STAT3 inhibitor exerts potent anti‐tumour activity by inducing lysosome‐dependent cell death
2025 · British Journal of Pharmacology · 3 citations
https://doi.org/10.1111/bph.70071
Multiomics Approach Distinguishes SPTBN4 as a Key Molecule in Diagnosis, Prognosis, and Immune Suppression of Testicular Seminomas
2025 · International Journal of Genomics · 1 citations
https://doi.org/10.1155/ijog/3530098
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat